Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.04) per share. This is a 63.64 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $27.61 million which beat the analyst consensus estimate of $21.60 million by 27.81 percent. This is a 119.97 percent increase over sales of $12.55 million the same period last year.
Avid Bioservices Q4 EPS $(0.04) Up From $(0.11) YoY, Sales $27.61M Beat $21.60M Estimate
Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.04) per share. This is a 63.64 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of